CH675967A5 - - Google Patents
Download PDFInfo
- Publication number
- CH675967A5 CH675967A5 CH4796/87A CH479687A CH675967A5 CH 675967 A5 CH675967 A5 CH 675967A5 CH 4796/87 A CH4796/87 A CH 4796/87A CH 479687 A CH479687 A CH 479687A CH 675967 A5 CH675967 A5 CH 675967A5
- Authority
- CH
- Switzerland
- Prior art keywords
- active substance
- preparation according
- tyrosine
- eak
- liposomes
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 claims description 44
- 239000013543 active substance Substances 0.000 claims description 42
- 239000002502 liposome Substances 0.000 claims description 23
- 210000003491 skin Anatomy 0.000 claims description 23
- -1 tyrosine D-glucose ester Chemical class 0.000 claims description 18
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 15
- 229960004441 tyrosine Drugs 0.000 claims description 14
- 230000000475 sunscreen effect Effects 0.000 claims description 11
- 239000000516 sunscreening agent Substances 0.000 claims description 11
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 11
- 239000002537 cosmetic Substances 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 claims description 8
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 7
- 239000012190 activator Substances 0.000 claims description 7
- 150000003667 tyrosine derivatives Chemical class 0.000 claims description 7
- 239000004904 UV filter Substances 0.000 claims description 6
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 6
- 210000002615 epidermis Anatomy 0.000 claims description 6
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 claims description 5
- 239000000969 carrier Substances 0.000 claims description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 5
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 4
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 claims description 4
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 claims description 4
- 101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 125000004674 methylcarbonyl group Chemical group CC(=O)* 0.000 claims description 3
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000000637 Melanocyte-Stimulating Hormone Substances 0.000 claims description 2
- 108010007013 Melanocyte-Stimulating Hormones Proteins 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 claims description 2
- 229930003268 Vitamin C Natural products 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 150000001340 alkali metals Chemical class 0.000 claims description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 229960001948 caffeine Drugs 0.000 claims description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 2
- 235000010376 calcium ascorbate Nutrition 0.000 claims description 2
- 229940047036 calcium ascorbate Drugs 0.000 claims description 2
- 239000011692 calcium ascorbate Substances 0.000 claims description 2
- BLORRZQTHNGFTI-ZZMNMWMASA-L calcium-L-ascorbate Chemical compound [Ca+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] BLORRZQTHNGFTI-ZZMNMWMASA-L 0.000 claims description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 2
- 235000018417 cysteine Nutrition 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 235000019192 riboflavin Nutrition 0.000 claims description 2
- 229960002477 riboflavin Drugs 0.000 claims description 2
- 239000002151 riboflavin Substances 0.000 claims description 2
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 claims description 2
- 229960004559 theobromine Drugs 0.000 claims description 2
- 229960000278 theophylline Drugs 0.000 claims description 2
- 235000019154 vitamin C Nutrition 0.000 claims description 2
- 239000011718 vitamin C Substances 0.000 claims description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 229960005305 adenosine Drugs 0.000 claims 1
- MWEQTWJABOLLOS-UHFFFAOYSA-L disodium;[[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-oxidophosphoryl] hydrogen phosphate;trihydrate Chemical compound O.O.O.[Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP([O-])(=O)OP(O)([O-])=O)C(O)C1O MWEQTWJABOLLOS-UHFFFAOYSA-L 0.000 claims 1
- 150000003904 phospholipids Chemical class 0.000 description 8
- 239000012141 concentrate Substances 0.000 description 6
- 230000037072 sun protection Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 210000002752 melanocyte Anatomy 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000005871 repellent Substances 0.000 description 2
- 239000008347 soybean phospholipid Substances 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- CAHKINHBCWCHCF-JTQLQIEISA-N N-acetyl-L-tyrosine Chemical compound CC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 CAHKINHBCWCHCF-JTQLQIEISA-N 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229960003001 adenosine triphosphate disodium Drugs 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 1
- 229960001682 n-acetyltyrosine Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 150000002888 oleic acid derivatives Chemical class 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 210000004694 pigment cell Anatomy 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/04—Preparations for care of the skin for chemically tanning the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Chemical & Material Sciences (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH4796/87A CH675967A5 (fr) | 1987-12-09 | 1987-12-09 | |
| DE3836849A DE3836849A1 (de) | 1987-12-09 | 1988-10-28 | Praeparat, kosmetisches sonnenschutzpraeparat sowie verfahren zum einbringen einer wirksubstanz in die haut |
| IT8812585A IT1225506B (it) | 1987-12-09 | 1988-11-16 | Preparato, in particolare preparato cosmetico antisolare, nonche' metodo per l'introduzione di una sostanza attiva nella pelle |
| AU25784/88A AU2578488A (en) | 1987-12-09 | 1988-11-21 | A product, cosmetic sunscreen product, and a method for introducing an active substance into the skin |
| ES8803666A ES2012158A6 (es) | 1987-12-09 | 1988-12-01 | Preparado y procedimiento para la incorporacion de una sustancia activa en la piel, asi como preparado cosmetico protector del sol. |
| FR8816073A FR2624374A1 (fr) | 1987-12-09 | 1988-12-07 | Preparation, notamment cosmetique antisolaire, et procede pour faire passer une substance active dans la peau |
| GB8828694A GB2213376A (en) | 1987-12-09 | 1988-12-08 | Liposomes containing active substance for regulating tanning of the skin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH4796/87A CH675967A5 (fr) | 1987-12-09 | 1987-12-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH675967A5 true CH675967A5 (fr) | 1990-11-30 |
Family
ID=4282697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH4796/87A CH675967A5 (fr) | 1987-12-09 | 1987-12-09 |
Country Status (7)
| Country | Link |
|---|---|
| AU (1) | AU2578488A (fr) |
| CH (1) | CH675967A5 (fr) |
| DE (1) | DE3836849A1 (fr) |
| ES (1) | ES2012158A6 (fr) |
| FR (1) | FR2624374A1 (fr) |
| GB (1) | GB2213376A (fr) |
| IT (1) | IT1225506B (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5449511A (en) * | 1989-09-15 | 1995-09-12 | The Gillette Company | Non-whitening antiperspirant composition |
| FR2653334B1 (fr) * | 1989-10-19 | 1991-12-20 | Erphar Ste Civile | Preparation cosmetique de bronzage. |
| AU6729290A (en) * | 1989-11-09 | 1991-06-13 | Schering-Plough Healthcare Products, Inc. | Riboflavin as a tanning enhancer |
| US5540914A (en) * | 1989-12-15 | 1996-07-30 | The Board Of Regents Of The University Of Oklahoma | Pigmentation enhancer and method |
| DE4121945C2 (de) * | 1991-07-03 | 1993-11-04 | Merz & Co Gmbh & Co | Verfahren zur herstellung von stabilen, hydrophilen oder ambiphilen creme-zubereitungen, enthaltend vesikulaere bestandteile, stabile creme-zubereitungen mit vesikulaeren bestandteilen und deren verwendung |
| US5318774A (en) * | 1992-02-28 | 1994-06-07 | Richardson-Vicks Inc. | Composition and method for imparting an artificial tan to human skin |
| FR2702959B1 (fr) * | 1993-03-25 | 1995-06-16 | Thorel Jean Noel | Nouvelles preparations cosmetiques ou pharmaceutiques, a usage topique. |
| EP0735857A1 (fr) * | 1993-12-21 | 1996-10-09 | The Board Of Regents Of The University Of Oklahoma | Procede et composition pour augmenter la pigmentation |
| GB9411115D0 (en) * | 1994-06-03 | 1994-07-27 | Secr Defence | Stabilisation of photosensitive material |
| JP3485375B2 (ja) | 1995-02-17 | 2004-01-13 | 株式会社資生堂 | 皮膚外用剤 |
| FR2753707B1 (fr) * | 1996-09-23 | 1998-12-11 | Complexes nucleopeptidiques, compositions cosmetologiques et pharmaceutiques les contenant et utilisations | |
| DE19958121A1 (de) | 1999-12-02 | 2001-06-28 | Max Planck Gesellschaft | Tyrosin- und tryptophanhaltige Peptide als Antioxidantien |
| NL1014389C2 (nl) * | 2000-02-15 | 2001-08-16 | Dija Zeist Bv | Bruiningspreparaat voor de huid. |
| FR2823112B1 (fr) * | 2001-04-09 | 2004-03-05 | Oreal | Produit bronzant et filtrant |
| CH693624A5 (it) * | 2003-05-22 | 2003-11-28 | Gecomwert Anstalt | Preparati per la protezione solare, abbronzanti e di trattamento della pelle esposta al sole, atti ad aumentare e prolungare l'abbronzatura. |
| DE102005026164A1 (de) * | 2005-06-06 | 2006-12-14 | Henkel Kgaa | Selbstbräunungszusammensetzungen mit UV-Schutzwirkung |
| EP2123285A1 (fr) * | 2008-05-21 | 2009-11-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Phosphoantigènes nucléosidiques à utiliser pour la thérapie liée à la cellule T VGAMMA9VDELTA2 |
| DE102010021688A1 (de) * | 2010-05-27 | 2011-12-01 | Qineva Gmbh & Co. Kg | Verfahren zur Herstellung eines micellaren Wirkstoffkonzentrats |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2416008A1 (fr) * | 1978-02-02 | 1979-08-31 | Oreal | Lyophilisats de liposomes |
| CH642537A5 (en) * | 1980-01-25 | 1984-04-30 | Uni Chemie Ag | Cosmetic sunscreen product |
| FR2534487B1 (fr) * | 1982-10-15 | 1988-06-10 | Dior Christian Parfums | Procede d'homogeneisation de dispersions de phases lamellaires lipidiques hydratees, et suspensions obtenues par ce procede |
| FR2591105B1 (fr) * | 1985-12-11 | 1989-03-24 | Moet Hennessy Rech | Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide. |
| FR2597345B1 (fr) * | 1986-04-22 | 1990-08-03 | Oreal | Composition cosmetique ou pharmaceutique a base d'une dispersion aqueuse de spherules lipidiques. |
| CH671514A5 (fr) * | 1986-12-03 | 1989-09-15 | Induchem Ag | |
| FR2623716B1 (fr) * | 1987-11-27 | 1991-04-05 | Lvmh Rech | Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la tyrosine ou un derive de tyrosine et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite pigmentante, l'incorporant |
| FR2609393A1 (fr) * | 1988-02-23 | 1988-07-15 | Serobiologiques Lab Sa | Composition notamment utile comme matiere de base pour la preparation de compositions pharmaceutiques, notamment dermatologiques et/ou cosmetiques comprenant une substance azotee, notamment aminoacides, oligo- ou polypeptides, proteines, et leurs derives, et composition pharmaceutique ou cosmetique ainsi preparee. |
| FR2609395B1 (fr) * | 1988-02-23 | 1992-01-10 | Serobiologiques Lab Sa | Utilisation de bases xanthiques comme principe actif d'une composition pharmaceutique, notamment dermatologique, ou cosmetique, composition notamment utile comme matiere de base pour la preparation de composition pharmaceutique ou cosmetique et composition pharmaceutique ou cosmetique ainsi preparee |
-
1987
- 1987-12-09 CH CH4796/87A patent/CH675967A5/de not_active IP Right Cessation
-
1988
- 1988-10-28 DE DE3836849A patent/DE3836849A1/de not_active Withdrawn
- 1988-11-16 IT IT8812585A patent/IT1225506B/it active
- 1988-11-21 AU AU25784/88A patent/AU2578488A/en not_active Abandoned
- 1988-12-01 ES ES8803666A patent/ES2012158A6/es not_active Expired - Lifetime
- 1988-12-07 FR FR8816073A patent/FR2624374A1/fr active Pending
- 1988-12-08 GB GB8828694A patent/GB2213376A/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| DE3836849A1 (de) | 1989-06-22 |
| GB8828694D0 (en) | 1989-01-11 |
| FR2624374A1 (fr) | 1989-06-16 |
| AU2578488A (en) | 1989-06-15 |
| IT8812585A0 (it) | 1988-11-16 |
| IT1225506B (it) | 1990-11-20 |
| ES2012158A6 (es) | 1990-03-01 |
| GB2213376A (en) | 1989-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH675967A5 (fr) | ||
| DE69204671T2 (de) | Kosmetisches oder pharmazeutisches, insbesondere dermatologisches mittel enthaltend einen cyperus extrakt, zur förderung des haut oder haare pigmentierung und herstellungsverfahren. | |
| DE2660069C2 (fr) | ||
| AT390372B (de) | Verwendung von solarfiltern zur stabilisierung und verbesserung der hautvertraeglichkeit von benzoylperoxyd enthaltenden zubereitungen zur lokalen aknebehandlung | |
| DE69017467T2 (de) | Verwendung von xanthinen, gegebenenfalls in liposomen eingebettet, zur förderung der haut- oder haarpigmentation. | |
| DE3875425T2 (de) | Vasokinetisch wirkende polyungesaettigte saeuren und sie enthaltende pharmazeutische oder kosmetische zubereitungen. | |
| DE69811263T2 (de) | Konjugierte linolsäure enthaltendes verteilungssystem in kosmetika | |
| DE69424537T2 (de) | Therapeutischer wirkstoff zur behandlung von melanomen | |
| DE69004212T2 (de) | Hautfärbende Zusammensetzung, die Indol-Derivate und Dihydroxyazeton enthält. | |
| DE69002539T2 (de) | Kosmetische Zubereitung gegen das Altern der Haut. | |
| DE3382637T2 (de) | Eine lipidloesliche substanz enthaltende waessrige fluessigkeit. | |
| DE69734114T2 (de) | Topische zusammensetzung und verfahren zur verbesserung der lipidbarrieresynthese | |
| DE68912195T2 (de) | Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis. | |
| DE69411812T2 (de) | Kosmetisches oder pharmazeutisches Präparat zur topischer Verwendung gegen freien Radikale | |
| DE3732154C2 (de) | Kosmetisches Sonnenschutz-Präparat für Gesicht und Körper | |
| EP0152106B1 (fr) | Antirhumatismaux | |
| DE3506576A1 (de) | Dermatologische zusammensetzung | |
| DE2707878C2 (de) | Verwendung von Mono- und/oder Diglyceriden mittelkettiger Fettsäuren | |
| EP0817610B1 (fr) | Preparation de gel ophtalmique sterile applicable en gouttes et son procede de production | |
| DE3414629A1 (de) | Zusammensetzung mit pharmazeutischer wirkung, neue therapeutische anwendung der zusammensetzung und verfahren zu deren herstellung | |
| DE68907335T2 (de) | Im wesentlichen aus Triglyceriden gesättigter Fettsäuren bestehende, mit einem Wirkstoff beladene Mikrogranulate und ihre äusserliche therapeutische Anwendung. | |
| DE69302396T2 (de) | Antiviral wirksame pharmazeutische öl in wasser-emulsion, die 9-[(2-hydroxyethoxy)methyl]-guanin (acyclovir) oder ein salz oder einen ester davon enthält | |
| DE68912022T2 (de) | Reizvermeidende und desensibilisierende Zusammensetzungen und Verfahren zu deren Anwendung. | |
| DE68905373T2 (de) | Kosmetische oder dermatologische anti-zellulitis oder schlankmachende zusammensetzung mit freien oder in liposomen kolaextrakten. | |
| DE69005860T2 (de) | Verwendung von 5'-Deoxy-5'-methylthioadenosin S-adenosylmethionin und dessen Salzen zur Herstellung von Seborrhea vermindernden Arzneimitteln. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |